Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New WHO Multidisciplinary Panel To Advise On Clinical Trial Best Practices

Executive Summary

A new WHO technical advisory group will help deliver the ambitions of the World Health Assembly’s 2022 resolution to strengthen global coordination on how clinical trials are conducted, evaluated and reported.

You may also be interested in...



WHO Lists Scientific & Ethical Features That All Good Clinical Trials Should Include

In response to a World Health Assembly resolution on strengthening the global clinical trial ecosystem, the World Health Organization has drawn up a new draft guideline on best practices for clinical trials updating and adapting its previous work on research capacity.

WHO Lists Scientific & Ethical Features That All Good Clinical Trials Should Include

In response to a World Health Assembly resolution on strengthening the global clinical trial ecosystem, the World Health Organization has drawn up a new draft guideline on best practices for clinical trials updating and adapting its previous work on research capacity.

EU Platform Trials Project Piques WHO’s Interest

The World Health Organization is developing a new best practice guideline on improving the quality and efficiency of clinical trials and is keen to learn what role platform trials can play on this front and their acceptability by the clinical trial community.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS147592

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel